Peer review reports
From: Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
| Original Submission |
| 26 Jan 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Author responded |
Author comments
|
| Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
| Publishing |
| 11 Jul 2016 |
Editorially accepted |
|
| 25 Jul 2016 |
Article published |
10.1186/s12885-016-2578-5
|
Learn about peer review
